Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.8M Buy
368,900
+75,200
+26% +$3.4M 0.09% 174
2026
Q1
$11.2M Buy
+293,700
New +$12.4M 0.07% 192
2025
Q3
Sell
-184,900
Closed -$14.1M 552
2025
Q2
$14.1M Buy
+184,900
New +$13.3M 0.09% 146
2025
Q1
Sell
-51,600
Closed -$3.16M 569
2024
Q4
$3.16M Buy
51,600
+32,900
+176% +$2.15M 0.02% 343
2024
Q3
$1.11M Buy
+18,700
New +$1.03M 0.01% 471
2018
Q3
Sell
-63,000
Closed -$3.25M 825
2018
Q2
$3.25M Buy
63,000
+49,000
+350% +$2.69M 0.06% 175
2018
Q1
$688K Hold
14,000
0.01% 406
2017
Q4
$494K Buy
+14,000
New +$424K 0.01% 491

Other funds holding NTNX

ING Group's NTNX Position: Q2 2026 in Review

ING Group increased its Nutanix (NTNX) stake by 26% in Q2 2026, buying an estimated $3.4M and bringing the position to 368,900 shares worth $18.8M. The position accounts for 0.09% of the portfolio, ranked #174.

ING Group first reported a position in NTNX in Q4 2017 and has held it in 8 quarters since. 562 funds tracked by Wall St. Rank hold NTNX as of Q2 2026.

  • ING Group held 368,900 shares of Nutanix worth $18.8M as of Q2 2026.
  • ING Group bought 75,200 Nutanix shares in Q2 2026, an estimated $3.4M.
  • Nutanix made up 0.09% of ING Group's portfolio in Q2 2026, its #174 holding.
  • ING Group first reported a position in Nutanix in Q4 2017 and has held it in 8 quarters since.
  • 562 funds tracked by Wall St. Rank held Nutanix as of Q2 2026.

Based on ING Group's 13F filing for Q2 2026, filed 13 Aug 2026.